Increased hospital costs associated with red blood cell transfusion

Transfusion

Volumn 55, Issue 5, 2015, Pages 1082-1089

  Trentino, Kevin M ^a   Farmer, Shannon L ^a,b   Swain, Stuart G ^a   Burrows, Sally A ^c   Hofmann, Axel ^a,b   Ienco, Rinaldo ^a   Pavey, Warren ^b   Daly, Frank F S ^d,e   Van Niekerk, Anton ^e   Webb, Steven A R ^c,f   Towler, Simon ^f,g   Leahy, Michael F ^c,h  

^a South Metropolitan Health Service   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d CURTIN UNIVERSITY   (Australia)

^e ROYAL PERTH HOSPITAL   (Australia)

^f FREMANTLE HOSPITAL   (Australia)

^g MONASH UNIVERSITY   (Australia)

^h FIONA STANLEY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; COHORT ANALYSIS; DIAGNOSIS RELATED GROUP; DOSE RESPONSE; EMERGENCY CARE; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH SERVICE; HOSPITAL COST; HOSPITAL PATIENT; HOSPITAL RUNNING COST; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; ECONOMICS; INTENSIVE CARE UNIT; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL COSTS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES;

EID: 84929290899     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12958     Document Type: Article

References (35)

1. Farmer SL, Towler SC, Leahy MF, et al. Drivers for change: Western Australia Patient Blood Management Program (WA PBMP), World Health Assembly (WHA) and Advisory Committee on Blood Safety and Availability (ACBSA). Best Pract Res Clin Anaesthesiol 2013;27:43-58.
2. Leahy MF, Roberts H, Mukhtar SA, et al. A pragmatic approach to embedding patient blood management in a tertiary hospital. Transfusion 2014;54:1133-1145.
3. Isbister JP,. The three-pillar matrix of patient blood management-an overview. Best Pract Res Clin Anaesthesiol 2013;27:69-84.
4. South Metropolitan Health Service. Patient blood management: reducing anaemia, transfusions & length of stay for knee patients. 2012 [cited 2013 Feb 15]. Available from: https://www.healthroundtable.org/GetNews/tabid/668/itemid/172/amid/1858/patient-blood-management-program-reducing-anaemia-transfusions-length-of-stay-f.aspx
5. Abraham I, Sun D,. The cost of blood transfusion in Western Europe as estimated from six studies. Transfusion 2012;52:1983-1988.
6. Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010;50:753-765.
7. Leahy MF, Mukhtar SA,. From blood transfusion to patient blood management: a new paradigm for patient care and cost assessment of blood transfusion practice. Intern Med J 2012;42:332-338.
8. Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014;311:1317-1326.
9. Bernard AC, Davenport DL, Chang PK, et al. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009;208:931-937, 37 e1-2; discussion 38-9.
10. Hofmann A, Farmer S, Shander A,. Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management. Oncologist 2011;16(Suppl 3):3-11.
11. Thomson A, Farmer S, Hofmann A, et al. Patient blood management-a new paradigm for transfusion medicine? ISBT Sci Ser 2009;4:423-435.
12. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013;368:11-21.
13. Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116:2544-2552.
14. Horvath KA, Acker MA, Chang H, et al. Blood transfusion and infection after cardiac surgery. Ann Thorac Surg 2013;95:2194-2201.
15. Hofmann A, Ozawa S, Farrugia A, et al. Economic considerations on transfusion medicine and patient blood management. Best Pract Res Clin Anaesthesiol 2013;27:59-68.
16. Morton J, Anastassopoulos KP, Patel ST, et al. Frequency and outcomes of blood products transfusion across procedures and clinical conditions warranting inpatient care: an analysis of the 2004 healthcare cost and utilization project nationwide inpatient sample database. Am J Med Qual 2010;25:289-296.
17. Jensen LS, Grunnet N, Hanberg-Sorensen F, et al. Cost-effectiveness of blood transfusion and white cell reduction in elective colorectal surgery. Transfusion 1995;35:719-722.
18. Blumberg N, Kirkley SA, Heal JM,. A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery. Am J Surg 1996;171:324-330.
19. Trentino KM, Swain SG, Burrows SA, et al. Measuring the incidence of hospital-acquired complications and their effect on length of stay using CHADx. Med J Aust 2013;199:543-547.
20. Mukhtar SA, Leahy MF, Trentino K, et al. Effectiveness of a patient blood management data system in monitoring blood use in Western Australia. Anaesth Intensive Care 2013;41:207-215.
21. Sundararajan V, Henderson T, Perry C, et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004;57:1288-1294.
22. Ehsani JP, Jackson T, Duckett SJ,. The incidence and cost of adverse events in Victorian hospitals 2003-04. Med J Aust 2006;184:551-555.
23. Jackson TJ, Michel JL, Roberts RF, et al. A classification of hospital-acquired diagnoses for use with routine hospital data. Med J Aust 2009;191:544-548.
24. National Blood Authority (Australia). Patient Blood Management Guidelines: Module 2-Perioperative. 2012.
25. National Blood Authority (Australia). Patient Blood Management Guidelines: Module 1-Critical Bleeding/Massive Transfusion. 2011.
26. Berger MD, Gerber B, Arn K, et al. Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantation. Haematologica 2012;97:116-122.
27. Middelburg RA, van de Watering LM, van der Bom JG,. Blood transfusions: good or bad? Confounding by indication, an underestimated problem in clinical transfusion research. Transfusion 2010;50:1181-1183.
28. Paone G, Brewer R, Theurer PF, et al. Preoperative predicted risk does not fully explain the association between red blood cell transfusion and mortality in coronary artery bypass grafting. J Thorac Cardiovasc Surg 2012;143:178-185.
29. Taylor RW, O'Brien J, Trottier SJ, et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med 2006;34:2302-2308; quiz 09.
30. Bennett-Guerrero E, Zhao Y, O'Brien SM, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 2010;304:1568-1575.
31. Frank SM, Savage WJ, Rothschild JA, et al. Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology 2012;117:99-106.
32. Rogers MA, Blumberg N, Heal JM, et al. Increased risk of infection and mortality in women after cardiac surgery related to allogeneic blood transfusion. J Womens Health (Larchmt) 2007;16:1412-1420.
33. Rogers MA, Blumberg N, Saint SK, et al. Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery. Am Heart J 2006;152:1028-1034.
34. The Joint Commission, editor. Proceedings from the National Summit on Overuse. National Summit on Overuse; 2012; Chicago.
35. Shander A, Fink A, Javidroozi M, et al. Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes. Transfus Med Rev 2011;25:232-46 e53.